Pizzatti’s group reported that SUZ12 was overexpressed in BP-CML, and that this was due to SUZ12 promoter activation by constitutively activated WNT pathway molecules including catenin P120, WNT11, and WNT5A. Here, WNT5A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.